https://miasteniacampania.it/news/ 2026-02-25T12:53:40+00:00 https://miasteniacampania.it/2026/02/12/rozanolixizumab-primo-farmaco-approvato-per-i-pazienti-con-miastenia-gravis-anti-musk/ 2026-02-12T16:20:25+00:00 https://miasteniacampania.it/2026/02/12/miastenia-gravis-i-primi-dati-real-life-italiani-su-zilucoplan/ 2026-02-12T16:24:10+00:00 https://miasteniacampania.it/2026/02/12/anche-in-italia-disponibile-lefgartigimod-in-formulazione-sottocutanea-per-lamiastenia-gravis/ 2026-02-12T16:37:29+00:00 https://miasteniacampania.it/2026/02/23/inebilizumab-nuovi-risultati-positivi-nel-trattamento-della-miastenia-gravisgeneralizzata/ 2026-02-23T17:49:19+00:00 https://miasteniacampania.it/2026/02/24/miastenia-gravis-confermata-lefficacia-e-la-sicurezza-a-lungo-termine-diravulizumab/ 2026-02-25T09:47:24+00:00 https://miasteniacampania.it/2026/02/12/neuroimmunologia-quando-il-sistema-nervoso-dialoga-con-il-sistema-immunitario/ 2026-02-25T12:53:40+00:00